Go back

Anti-HIV gel clinical trials should start next month

The Follow-on Africa Consortium for Tenofovir Studies (FACTS) received approval this week to go ahead with a large study of an anti-HIV gel meant for women.

Final approval came from South Africa’s Medicines Control Council (MCC), according to Deborah Baron, the consortium manager.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.